Search Results - "Urinary Bladder Neoplasms pathology"
-
1
Authors: et al.
Source: Ann Surg Oncol
Subject Terms: Male, Paraplegia, Bladder, ICU, Morbidity, NIS, Surgery, Urinary Bladder Neoplasms/complications [MeSH], Aged [MeSH], Postoperative Complications/mortality [MeSH], Risk Factors [MeSH], Hospital Mortality [MeSH], Urinary Bladder Neoplasms/surgery [MeSH], Male [MeSH], Intraoperative Complications/mortality [MeSH], Postoperative Complications/etiology [MeSH], Paraplegia/mortality [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Urinary Bladder Neoplasms/mortality [MeSH], Cystectomy/adverse effects [MeSH], Middle Aged [MeSH], Urinary Bladder Neoplasms/pathology [MeSH], Paraplegia/etiology [MeSH], Survival Rate [MeSH], Urologic Oncology, Prognosis [MeSH], Cystectomy/mortality [MeSH], Middle Aged, Cystectomy, Prognosis, Survival Rate, Postoperative Complications, Urinary Bladder Neoplasms, Risk Factors, Humans, Female, Hospital Mortality, Intraoperative Complications, Aged, Follow-Up Studies, Retrospective Studies
File Description: application/pdf
-
2
Authors:
Source: Virchows Arch
Subject Terms: Pathologists, Bladder cancer, Surveys and Questionnaires [MeSH], Humans [MeSH], Tissue Fixation/methods [MeSH], Urinary Bladder Neoplasms/pathology [MeSH], Cystectomy [MeSH], Neoplasm, Residual/pathology [MeSH], Pathological response score, Cystectomy, Health Care Surveys [MeSH], Pathologists [MeSH], Original Article, Urinary Bladder Neoplasms/surgery [MeSH], Grossing, Practice Patterns, Physicians'/statistics, Dissection, Neoadjuvant chemotherapy, Pathology, Surgical/methods [MeSH], Neoplasm, Residual, Tissue Fixation, Urinary Bladder Neoplasms, Pathology, Surgical, Health Care Surveys, Surveys and Questionnaires, Humans, Practice Patterns, Physicians'
-
3
Authors: et al.
Source: Urologie
Die Urologie, 63(10):1019-1027Subject Terms: Übersichten, Muscle invasive bladder carcinoma, Urothelial carcinoma, Perioperative systemic therapy, Humans [MeSH], Urinary Bladder Neoplasms/drug therapy [MeSH], Perioperative Systemtherapie, Perioperative Care/methods [MeSH], Urinary Bladder Neoplasms/pathology [MeSH], Neoplasm Invasiveness [MeSH], Cystectomy [MeSH], B7-H1 Antigen/metabolism [MeSH], Immune Checkpoint Inhibitors/therapeutic use [MeSH], PD-L1 testing, Urinary Bladder Neoplasms/surgery [MeSH], Urothelkarzinom, B7-H1 Antigen/antagonists, Germany [MeSH], Immune checkpoint inhibitor, Immun-Checkpoint-Inhibitor, PD-L1-Testung, Consensus [MeSH], Muskelinvasives Blasenkarzinom, Immune Checkpoint Inhibitors/pharmacology [MeSH]
File Description: application/pdf
-
4
Authors: et al.
Source: Virchows Arch
Subject Terms: Male, Adult, Aged, 80 and over, Cell Differentiation, Middle Aged, Carcinoma, Neuroendocrine, Female [MeSH], Telomerase/genetics [MeSH], Mutation [MeSH], Small cell neuroendocrine carcinoma, Aged, 80 and over [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Urinary bladder, Middle Aged [MeSH], Urinary Bladder Neoplasms/pathology [MeSH], Cell Differentiation [MeSH], Rhabdomyosarcoma/genetics [MeSH], Rhabdomyosarcoma, Carcinoma, Small Cell/genetics [MeSH], Original Article, Carcinoma, Small Cell/pathology [MeSH], Male [MeSH], Biomarkers, Tumor/genetics [MeSH], Carcinoma, Neuroendocrine/pathology [MeSH], Urinary Bladder Neoplasms/genetics [MeSH], Carcinoma, Neuroendocrine/genetics [MeSH], Biomarkers, Tumor/analysis [MeSH], Rhabdomyosarcoma/pathology [MeSH], 03 medical and health sciences, 0302 clinical medicine, Urinary Bladder Neoplasms, Mutation, Biomarkers, Tumor, Humans, Female, Carcinoma, Small Cell, Telomerase, Aged
-
5
Authors: et al.
Source: Dermatologie (Heidelb)
Subject Terms: Kasuistiken, Harnblase, Urinary Bladder Neoplasms/complications [MeSH], Carcinoma, Transitional Cell/complications [MeSH], Aged [MeSH], Humans [MeSH], Urinary bladder, Cancer-related lymphedema, Carcinoma, Transitional Cell/diagnosis [MeSH], Plasmacytoid urothelial carcinoma, Urinary Bladder Neoplasms/pathology [MeSH], Lymphedema/etiology [MeSH], Histomorphologie, Lymphedema/pathology [MeSH], Carcinoma, Transitional Cell/pathology [MeSH], Urinary Bladder Neoplasms/surgery [MeSH], Lokalisiertes Lymphödem, Localized lymphedema, Male [MeSH], Carcinoma, Transitional Cell/surgery [MeSH], Tumor-assoziiertes Lymphödem, Histomorphology, Plasmazytoides Urothelkarzinom
-
6
Authors: et al.
Source: Eur J Nucl Med Mol Imaging
Subject Terms: Male, Staging, PET/CT imaging, Short Communication, fap, Pilot Projects, Cystectomy, FAPI, 03 medical and health sciences, cystectomy, 0302 clinical medicine, Positron Emission Tomography Computed Tomography, 80 and over, Humans, nuclear medicine, urothelial carcinoma, Gallium Isotopes, Aged, Neoplasm Staging, Aged, 80 and over, Imaging / Radiology, Bladder cancer, FAP, staging, Middle Aged, FAPi, Lymph Nodes/pathology [MeSH], Urothelial carcinoma, Aged, 80 and over [MeSH], Aged [MeSH], Cystectomy [MeSH], Neoplasm Staging [MeSH], Urinary Bladder Neoplasms/surgery [MeSH], Male [MeSH], Female [MeSH], Humans [MeSH], Gallium Isotopes [MeSH], Positron Emission Tomography Computed Tomography [MeSH], Middle Aged [MeSH], Urinary Bladder Neoplasms/pathology [MeSH], Lymph Nodes/diagnostic imaging [MeSH], Lymphatic Metastasis/diagnostic imaging [MeSH], Quinolines [MeSH], Pilot Projects [MeSH], Urinary Bladder Neoplasms/diagnostic imaging [MeSH], Urinary Bladder Neoplasms, cardiology, Lymphatic Metastasis, oncology, Quinolines, bladder cancer, orthopedics, Female, Lymph Nodes
File Description: application/pdf
-
7
Authors: et al.
Source: Journal for ImmunoTherapy of Cancer, 13 (5), e012045 (2025-05-24)
Subject Terms: Bladder Cancer, Genitourinary Cancer, Immune Checkpoint Inhibitor, Neoadjuvant, Antibodies, Monoclonal, Humanized, avelumab, Cisplatin, Gemcitabine, Deoxycytidine, Humans, Male, Female, Aged, Middle Aged, Cisplatin/administration & dosage, Aged, 80 and over, Neoplasm Invasiveness, Deoxycytidine/analogs & derivatives, Deoxycytidine/administration & dosage, Urinary Bladder Neoplasms/drug therapy, Urinary Bladder Neoplasms/pathology, Urinary Bladder Neoplasms/mortality, Neoadjuvant Therapy/methods, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/pharmacology, Antibodies, Monoclonal, Humanized/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols, Neoadjuvant Therapy, Urinary Bladder Neoplasms, Immunology and Allergy, Immunology, Molecular Medicine, Oncology, Pharmacology, Cancer Research, Human health sciences, Sciences de la santé humaine, Oncologie
Relation: https://syndication.highwire.org/content/doi/10.1136/jitc-2025-012045; urn:issn:2051-1426
Access URL: https://orbi.uliege.be/handle/2268/333581
-
8
Authors: et al.
Source: Scandinavian Journal of Urology. 58:120-125
Subject Terms: Local/epidemiology, Urinary Bladder, Carcinoma, Cystoscopy, Aminolevulinic Acid, 3. Good health, Neoplasm Recurrence, Urinary Bladder Neoplasms, Urinary Bladder/surgery, Humans, Neoplasm Recurrence, Local, Carcinoma/pathology, Urinary Bladder Neoplasms/pathology, Retrospective Studies
-
9
Authors: et al.
Source: Int Urol Nephrol
Kaczmarek, K, Plage, H, Furlano, K, Hofbauer, S, Weinberger, S, Ralla, B, Franz, A, Fendler, A, de Martino, M, Roßner, F, Schallenberg, S, Elezkurtaj, S, Kluth, M, Lennartz, M, Blessin, N C, Marx, A H, Samtleben, H, Fisch, M, Rink, M, Slojewski, M, Ecke, T, Hallmann, S, Koch, S, Adamini, N, Minner, S, Simon, R, Sauter, G, Weischenfeldt, J, Klatte, T, Schlomm, T, Horst, D & Zecha, H 2024, ' Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder ', International Urology and Nephrology, vol. 56, pp. 499-508 . https://doi.org/10.1007/s11255-023-03800-0Subject Terms: Carcinoma, Transitional Cell, Upk1a, Urinary Bladder/pathology [MeSH], Urothelial carcinoma, Immunohistochemistry, Upk1b, Humans [MeSH], Diagnostic marker, Uroplakin Ib/metabolism [MeSH], Urinary Bladder Neoplasms/pathology [MeSH], Tissue microarray, Carcinoma, Transitional Cell/pathology [MeSH], Biomarkers, Tumor/metabolism [MeSH], Uroplakin Ia/metabolism [MeSH], Urology - Original Paper, Urinary Bladder, 3. Good health, Urinary Bladder Neoplasms, Biomarkers, Tumor, Humans, Uroplakin Ia, Uroplakin Ib
File Description: application/pdf
-
10
Authors: et al.
Source: World J Urol
World journal of urology, vol. 42, no. 1, pp. 527Subject Terms: Follow-up, Trimodal treatment, Follow-Up Studies [MeSH], Humans [MeSH], Urinary Bladder Neoplasms/pathology [MeSH], Neoplasm Invasiveness [MeSH], Urinary Bladder Neoplasms/therapy [MeSH], Trimodality, Original Article, Cystectomy/methods [MeSH], Bladder preservation, Functional outcomes, Neoplasm Recurrence, Local [MeSH], Combined Modality Therapy [MeSH], Oncological outcomes, Cystectomy, Combined Modality Therapy, Urinary Bladder Neoplasms, Humans, Urinary Bladder Neoplasms/therapy, Urinary Bladder Neoplasms/pathology, Neoplasm Invasiveness, Neoplasm Recurrence, Local, Follow-Up Studies, Cystectomy/methods
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/39297968
https://serval.unil.ch/notice/serval:BIB_30B9633467AB
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_30B9633467AB9
https://serval.unil.ch/resource/serval:BIB_30B9633467AB.P001/REF.pdf
https://repository.publisso.de/resource/frl:6522713 -
11
Authors: et al.
Source: Cancer Immunol Immunother
Cancer Immunology, Immunotherapy, Vol 74, Iss 1, Pp 1-10 (2024)Subject Terms: Male, Urologic Neoplasms, Target trial emulation, Drug-Related Side Effects and Adverse Reactions, Immune checkpoint inhibitors, 03 medical and health sciences, 0302 clinical medicine, Urothelial cancer, Humans, Immortal time bias, Aged, 80 and over [MeSH], Aged [MeSH], Urinary Bladder Neoplasms/drug therapy [MeSH], Metastatic, Drug-Related Side Effects and Adverse Reactions/etiology [MeSH], Adverse events, Male [MeSH], Immune Checkpoint Inhibitors/adverse effects [MeSH], Urologic Neoplasms/mortality [MeSH], Carcinoma, Transitional Cell/drug therapy [MeSH], Carcinoma, Transitional Cell/mortality [MeSH], Female [MeSH], Carcinoma, Transitional Cell/immunology [MeSH], Urologic Neoplasms/drug therapy [MeSH], Humans [MeSH], Neoplasm Metastasis [MeSH], Retrospective Studies [MeSH], Urinary Bladder Neoplasms/mortality [MeSH], Middle Aged [MeSH], Urinary Bladder Neoplasms/immunology [MeSH], Urinary Bladder Neoplasms/pathology [MeSH], Immune Checkpoint Inhibitors/therapeutic use [MeSH], Urologic Neoplasms/immunology [MeSH], Research, Immunotherapy, Urologic Neoplasms/pathology [MeSH], Neoplasm Metastasis, Immune Checkpoint Inhibitors, RC254-282, Aged, Retrospective Studies, Aged, 80 and over, Carcinoma, Transitional Cell, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Urinary Bladder Neoplasms, Female
-
12
Authors: et al.
Contributors: et al.
Source: American Journal of Surgical Pathology. 48:e11-e23
Subject Terms: Carcinoma, Transitional Cell, Urinary Bladder Neoplasms / pathology, Urinary Bladder, Urinary Bladder / pathology, 616.07, 16. Peace & justice, 3. Good health, Carcinoma, Transitional Cell / pathology, Carcinoma in Situ / pathology, Urinary Bladder Neoplasms, Carcinoma, Squamous Cell / pathology, Carcinoma, Squamous Cell, Humans, Neoplasm Grading, Urinary Bladder Neoplasms / therapy, Carcinoma in Situ
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/37382156
-
13
Authors: et al.
Source: Zlotta, A R, Ballas, L K, Niemierko, A, Lajkosz, K, Kuk, C, Miranda, G, Drumm, M, Mari, A, Thio, E, Fleshner, N E, Kulkarni, G S, Jewett, M A S, Bristow, R G, Catton, C, Berlin, A, Sridhar, S S, Schuckman, A, Feldman, A S, Wszolek, M, Dahl, D M, Lee, R J, Saylor, P J, Michaelson, M D, Miyamoto, D T, Zietman, A, Shipley, W, Chung, P, Daneshmand, S & Efstathiou, J A 2023, 'Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer : a multi-institutional propensity score matched and weighted analysis', The Lancet. Oncology, vol. 24, no. 6, pp. 669-681. https://doi.org/10.1016/S1470-2045(23)00170-5
Subject Terms: Male, Carcinoma, Transitional Cell, Muscles, Carcinoma, Urinary Bladder, Carcinoma, Transitional Cell/drug therapy, Cystectomy, 3. Good health, Muscles/pathology, Treatment Outcome, Urinary Bladder Neoplasms, Urinary Bladder/pathology, Cystectomy/adverse effects, Humans, Female, Transitional Cell/drug therapy, Propensity Score, Urinary Bladder Neoplasms/pathology, Aged, Retrospective Studies, Urinary Bladder/pathology/surgery
File Description: application/pdf
-
14
Authors: et al.
Source: World J Urol
Subject Terms: Carcinoma, Transitional Cell, 03 medical and health sciences, 0302 clinical medicine, Urinary Bladder Neoplasms, Ureter/surgery [MeSH], Humans [MeSH], Kidney Neoplasms/surgery [MeSH], Kidney Neoplasms/pathology [MeSH], Urinary Bladder Neoplasms/pathology [MeSH], Upper tract urinary cancer, Radical nephroureterectomy, Intravesical recurrence, Carcinoma, Transitional Cell/pathology [MeSH], Ureteral Neoplasms/surgery [MeSH], Urinary Bladder Neoplasms/surgery [MeSH], Nephroureterectomy/methods [MeSH], Research, Carcinoma, Transitional Cell/surgery [MeSH], Neoplasm Recurrence, Local/epidemiology [MeSH], Ureteral Neoplasms, Humans, Neoplasm Recurrence, Local, Ureter, Nephroureterectomy, Kidney Neoplasms
-
15
Authors: et al.
Contributors: et al.
Source: Pathology. 55:19-30
Subject Terms: Squamous Cell Carcinoma of Head and Neck / diagnosis, Lung Neoplasms, Lung Neoplasms* / diagnosis, B7-H1 Antigen, 03 medical and health sciences, Transitional Cell, 0302 clinical medicine, Non-Small-Cell Lung* / diagnosis, Neoplasms, Carcinoma, Non-Small-Cell Lung, XXXXXX - Unknown, Non-Small-Cell Lung* / pathology, Biomarkers, Tumor, Humans, Neoplasms, Squamous Cell, reproducibility, Lung Neoplasms* / pathology, Urinary Bladder Neoplasms* / pathology, Carcinoma, Transitional Cell, Tumor, reliability, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Reproducibility of Results, SP263, Immunohistochemistry, 3. Good health, 22C3, Squamous Cell, Urinary Bladder Neoplasms, Head and Neck Neoplasms, Head and Neck Neoplasms* / diagnosis, Biomarkers, interchangeability
File Description: print
Access URL: https://pubmed.ncbi.nlm.nih.gov/36319485
-
16
Authors: Bebek, Marko
Source: Practical radiation oncology. 66(1):120-137
Subject Terms: Smooth / pathology* Neoplasm Invasiveness Radiotherapy Urinary Bladder / pathology* Urinary Bladder Neoplasms / pathology* Urinary Bladder Neoplasms / therapy, Humans Urinary Bladder Neoplasms* / radiotherapy Antineoplastic Agents / therapeutic use Combined Modality Therapy / methods Muscle
-
17
Authors: et al.
Source: BMC Urol
BMC Urology, Vol 24, Iss 1, Pp 1-9 (2024)
Plage, H, Furlano, K, Hofbauer, S, Weinberger, S, Ralla, B, Franz, A, Fendler, A, de Martino, M, Roßner, F, Elezkurtaj, S, Kluth, M, Lennartz, M, Blessin, N C, Marx, A H, Samtleben, H, Fisch, M, Rink, M, Slojewski, M, Kaczmarek, K, Ecke, T, Hallmann, S, Koch, S, Adamini, N, Zecha, H, Minner, S, Simon, R, Sauter, G, Weischenfeldt, J, Klatte, T, Schlomm, T, Horst, D & Schallenberg, S 2024, ' PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors ', BMC Urology, vol. 24, 96 . https://doi.org/10.1186/s12894-024-01482-zSubject Terms: PD-L1, Male, Aged, 80 and over, 0301 basic medicine, Carcinoma, Transitional Cell, Research, Middle Aged, Prognosis, Immunohistochemistry, Diseases of the genitourinary system. Urology, B7-H1 Antigen, Tissue microarray, 3. Good health, Urothelial bladder carcinomas, 03 medical and health sciences, 0302 clinical medicine, Urinary Bladder Neoplasms, Humans, Female, Neoplasm Invasiveness, Female [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], B7-H1 Antigen/analysis [MeSH], Urinary Bladder Neoplasms/metabolism [MeSH], Humans [MeSH], Urinary Bladder Neoplasms/drug therapy [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Urinary Bladder Neoplasms/pathology [MeSH], Neoplasm Invasiveness [MeSH], Immune Checkpoint Inhibitors/therapeutic use [MeSH], Carcinoma, Transitional Cell/pathology [MeSH], Male [MeSH], Carcinoma, Transitional Cell/drug therapy [MeSH], Prognosis [MeSH], Carcinoma, Transitional Cell/metabolism [MeSH], B7-H1 Antigen/biosynthesis [MeSH], RC870-923, Immune Checkpoint Inhibitors, Aged, Retrospective Studies
File Description: application/pdf
-
18
Authors: et al.
Source: World J Urol
Subject Terms: Margins of Excision, Middle Aged, Urinary Diversion, Cystectomy, Bladder cancer, Perioperative outcomes, Aged [MeSH], Hemoglobins [MeSH], Humans [MeSH], Prospective Studies [MeSH], Treatment Outcome [MeSH], Urinary Diversion [MeSH], Margins of Excision [MeSH], Retrospective Studies [MeSH], Cystectomy/adverse effects [MeSH], Middle Aged [MeSH], Risk Factors [MeSH], Urinary Bladder Neoplasms/pathology [MeSH], Cohort Studies [MeSH], Original Article, Survival, Creatinine [MeSH], Postoperative Complications/etiology [MeSH], Cohort Studies, Hemoglobins, 03 medical and health sciences, Postoperative Complications, Treatment Outcome, 0302 clinical medicine, Urinary Bladder Neoplasms, Risk Factors, Creatinine, Humans, Prospective Studies, Aged, Retrospective Studies
-
19
Authors: et al.
Source: Sci Rep
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Demir, R, Koc, S, Ozturk, D G, Bilir, S, Ozata, H I, Williams, R, Christy, J R E, Akkoc, Y, Tinay, I, Gunduz-Demir, C & Gozuacik, D 2024, ' Artificial intelligence assisted patient blood and urine droplet pattern analysis for non‑invasive and accurate diagnosis of bladder cancer ', Scientific Reports, vol. 14, no. 1, 2488, pp. 2488 . https://doi.org/10.1038/s41598-024-52728-7Subject Terms: Science, Urinary Bladder, Reproducibility of Results, Article, 6. Clean water, 3. Good health, Biomarkers, Tumor/urine, Urinary Bladder Neoplasms, Urinary Bladder/pathology, Artificial Intelligence, Biomarkers, Tumor, Medicine, Humans, Urinary Bladder Neoplasms/pathology
File Description: application/pdf
-
20
Authors: et al.
Source: Front Immunol
Frontiers in Immunology, Vol 14 (2024)
Frontiers in immunology, vol. 14, pp. 1335326Subject Terms: Immunology, cancer, Immunology, innate lymphoid cell (ILC), type 2 innate lymphoid cell (ILC2), bladder cancer, tumor microenvironment, MB49 bladder tumor model, Mice, innate lymphoid cell (ILC), Humans, Animals, Immunity, Innate, Interleukin-33/metabolism, Lymphocytes, Lung, Urinary Bladder Neoplasms/pathology, Tumor Microenvironment, MB49 bladder tumor model, bladder cancer, tumor microenvironment, type 2 innate lymphoid cell (ILC2), cancer, RC581-607, Interleukin-33, CANCER, 3. Good health, Urinary Bladder Neoplasms, Innate immunology, Immunologic diseases. Allergy
File Description: application/pdf
Full Text Finder 
Nájsť tento článok vo Web of Science 
Full Text